ReP USP - Resultado da busca

Artigo de periodico
SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid leukemia cells (2020)
Silveira, Vanessa da Silva ; Borges, Kleiton Silva; Santos, Verena Silva; Ruckert, Mariana Tannús; Vieira, Gabriela Maciel; Vasconcelos, Elton José Rosas de; Nagano, Luis Fernando ; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto
Source: Scientific Reports. Unidade: FMRP
Subjects: ANTINEOPLÁSICOS, APOPTOSE, LINHAGEM CELULAR, DANO AO DNA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Vanessa da Silva et al. SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid leukemia cells. Scientific Reports, v. 10, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-72124-1. Acesso em: 03 nov. 2024.
APA
Silveira, V. da S., Borges, K. S., Santos, V. S., Ruckert, M. T., Vieira, G. M., Vasconcelos, E. J. R. de, et al. (2020). SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid leukemia cells. Scientific Reports, 10( 1). doi:10.1038/s41598-020-72124-1
NLM
Silveira V da S, Borges KS, Santos VS, Ruckert MT, Vieira GM, Vasconcelos EJR de, Nagano LF, Tone LG, Scrideli CA. SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid leukemia cells [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1038/s41598-020-72124-1
Vancouver
Silveira V da S, Borges KS, Santos VS, Ruckert MT, Vieira GM, Vasconcelos EJR de, Nagano LF, Tone LG, Scrideli CA. SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid leukemia cells [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1038/s41598-020-72124-1
Artigo de periodico
Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells (2012)
Castro-Gamero, Angel Mauricio; Borges, Kleiton Silva; Silveira, Vanessa da Silva; Lira, Regia Caroline Peixoto; Queiroz, Rosane Gomes de Paula; Valera, Fabiana Cardoso Pereira; Scrideli, Carlos Alberto; Umezawa, Kazuo; Tone, Luiz Gonzaga
Source: Anti-Cancer Drugs. Unidade: FMRP
Subjects: OSTEOSSARCOMA (TRATAMENTO;EFEITOS DE DROGAS), NEOPLASIAS ÓSSEAS, APOPTOSE, QUIMIOTERÁPICOS (COMBINAÇÃO), ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO-GAMERO, Angel Mauricio et al. Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells. Anti-Cancer Drugs, v. 23, n. 6, 2012Tradução . . Disponível em: https://doi.org/10.1097/CAD.0b013e328350e835. Acesso em: 03 nov. 2024.
APA
Castro-Gamero, A. M., Borges, K. S., Silveira, V. da S., Lira, R. C. P., Queiroz, R. G. de P., Valera, F. C. P., et al. (2012). Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells. Anti-Cancer Drugs, 23( 6). doi:10.1097/CAD.0b013e328350e835
NLM
Castro-Gamero AM, Borges KS, Silveira V da S, Lira RCP, Queiroz RG de P, Valera FCP, Scrideli CA, Umezawa K, Tone LG. Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells [Internet]. Anti-Cancer Drugs. 2012 ; 23( 6):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1097/CAD.0b013e328350e835
Vancouver
Castro-Gamero AM, Borges KS, Silveira V da S, Lira RCP, Queiroz RG de P, Valera FCP, Scrideli CA, Umezawa K, Tone LG. Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells [Internet]. Anti-Cancer Drugs. 2012 ; 23( 6):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1097/CAD.0b013e328350e835
Artigo de periodico
Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis (2012)
Lorea, Cecília Fernandes; Moreno, Daniel Antunes; Borges, Kleiton Silva; Martinelli Junior, Carlos Eduardo; Antonini, Sonir Roberto Rauber; Castro, Margaret de; Tucci Júnior, Silvio; Neder, Luciano; Ramalho, Leandra Naíra Zambelli; Cardinalli, Izilda; Seidinger, Ana Luiza; Mastellaro, Maria José; Yunes, Jose Andres; Brandalise, Silvia Regina; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: European journal of Endocrinology. Unidade: FMRP
Subjects: APOPTOSE, CRIANÇAS, NEOPLASIAS DAS GLÂNDULAS SUPRARRENAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOREA, Cecília Fernandes et al. Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis. European journal of Endocrinology, v. 167, n. 12, p. 199-208, 2012Tradução . . Disponível em: https://doi.org/10.1530/EJE-12-0183. Acesso em: 03 nov. 2024.
APA
Lorea, C. F., Moreno, D. A., Borges, K. S., Martinelli Junior, C. E., Antonini, S. R. R., Castro, M. de, et al. (2012). Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis. European journal of Endocrinology, 167( 12), 199-208. doi:10.1530/EJE-12-0183
NLM
Lorea CF, Moreno DA, Borges KS, Martinelli Junior CE, Antonini SRR, Castro M de, Tucci Júnior S, Neder L, Ramalho LNZ, Cardinalli I, Seidinger AL, Mastellaro MJ, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis [Internet]. European journal of Endocrinology. 2012 ; 167( 12): 199-208.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1530/EJE-12-0183
Vancouver
Lorea CF, Moreno DA, Borges KS, Martinelli Junior CE, Antonini SRR, Castro M de, Tucci Júnior S, Neder L, Ramalho LNZ, Cardinalli I, Seidinger AL, Mastellaro MJ, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis [Internet]. European journal of Endocrinology. 2012 ; 167( 12): 199-208.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1530/EJE-12-0183
Trabalho de evento-resumo periodico
Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells (2011)
Castro-Gamero, Angel Mauricio; Borges, Kleiton Silva; Moreno, Daniel Antunes; Carlotti Júnior, Carlos Gilberto; Scridelli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: NEOPLASIAS (TRATAMENTO), FÁRMACOS, PROTEÍNAS, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO-GAMERO, Angel Mauricio et al. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 03 nov. 2024. , 2011
APA
Castro-Gamero, A. M., Borges, K. S., Moreno, D. A., Carlotti Júnior, C. G., Scridelli, C. A., & Tone, L. G. (2011). Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Castro-Gamero AM, Borges KS, Moreno DA, Carlotti Júnior CG, Scridelli CA, Tone LG. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. 2011 ; 57( 5): 718.[citado 2024 nov. 03 ]
Vancouver
Castro-Gamero AM, Borges KS, Moreno DA, Carlotti Júnior CG, Scridelli CA, Tone LG. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. 2011 ; 57( 5): 718.[citado 2024 nov. 03 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Indexado em